V. Fermeaux

1.1k total citations
30 papers, 847 citations indexed

About

V. Fermeaux is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, V. Fermeaux has authored 30 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in V. Fermeaux's work include Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (4 papers) and Cancer Diagnosis and Treatment (3 papers). V. Fermeaux is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (4 papers) and Cancer Diagnosis and Treatment (3 papers). V. Fermeaux collaborates with scholars based in France and United States. V. Fermeaux's co-authors include Y. Aubard, Bruno Coudert, Colette Migeon, L. Benoît, Frédérique Penault‐Llorca, P Bertheau, Laurent Arnould, Franck Bonnetain, Véronique Cabaret and J. L. Garnier and has published in prestigious journals such as Journal of Clinical Microbiology, British Journal of Cancer and Human Reproduction.

In The Last Decade

V. Fermeaux

29 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Fermeaux France 10 400 255 208 194 158 30 847
C. Gattringer Austria 12 408 1.0× 100 0.4× 342 1.6× 45 0.2× 234 1.5× 45 939
Björn E. Wahlin Sweden 18 830 2.1× 71 0.3× 104 0.5× 64 0.3× 493 3.1× 88 1.5k
W. Christopher Ehmann United States 18 762 1.9× 85 0.3× 216 1.0× 66 0.3× 600 3.8× 43 1.4k
WC Chan United States 19 718 1.8× 97 0.4× 219 1.1× 94 0.5× 707 4.5× 26 1.6k
Ming-Sheng Lee United States 8 445 1.1× 45 0.2× 209 1.0× 106 0.5× 242 1.5× 10 1.0k
Barbara Gamberi Italy 18 440 1.1× 48 0.2× 444 2.1× 107 0.6× 114 0.7× 70 1.1k
Andrea Palicelli Italy 14 238 0.6× 35 0.1× 133 0.6× 40 0.2× 89 0.6× 112 732
Béatrice Clemenceau France 21 449 1.1× 129 0.5× 233 1.1× 22 0.1× 590 3.7× 50 1.2k
Paul M. Sondel United States 17 421 1.1× 119 0.5× 184 0.9× 58 0.3× 767 4.9× 41 1.1k
Michael Varello United States 12 208 0.5× 98 0.4× 241 1.2× 26 0.1× 74 0.5× 15 578

Countries citing papers authored by V. Fermeaux

Since Specialization
Citations

This map shows the geographic impact of V. Fermeaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Fermeaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Fermeaux more than expected).

Fields of papers citing papers by V. Fermeaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Fermeaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Fermeaux. The network helps show where V. Fermeaux may publish in the future.

Co-authorship network of co-authors of V. Fermeaux

This figure shows the co-authorship network connecting the top 25 collaborators of V. Fermeaux. A scholar is included among the top collaborators of V. Fermeaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Fermeaux. V. Fermeaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Deluche, Élise, Laurence Venat‐Bouvet, Sophie Léobon, et al.. (2017). Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers. BMC Cancer. 17(1). 662–662. 4 indexed citations
3.
Venat‐Bouvet, Laurence, V. Fermeaux, Sophie Léobon, et al.. (2014). Adjuvant chemotherapy in node-negative breast cancer: UPA/PAI-1 determinations for 163 cases.. PubMed. 34(3). 1213–7. 5 indexed citations
4.
Gauthier, Tristan, et al.. (2012). Lanreotide autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: A phase III double blind, randomized, placebo-controlled trial. European Journal of Surgical Oncology. 38(10). 902–909. 8 indexed citations
6.
Gauthier, Tristan, et al.. (2008). Axillary recurrence after negative sentinel lymph node biopsy under local anesthesia in breast cancer. European Journal of Surgical Oncology. 35(5). 464–468. 12 indexed citations
7.
Chassaing, Nicolas, Brigitte Gilbert‐Dussardier, Florence Nicot, et al.. (2007). Germinal mosaicism and familial recurrence of a SOX2 mutation with highly variable phenotypic expression extending from AEG syndrome to absence of ocular involvement. American Journal of Medical Genetics Part A. 143A(3). 289–291. 38 indexed citations
8.
Arnould, Laurent, Frédérique Penault‐Llorca, L. Benoît, et al.. (2006). Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?. British Journal of Cancer. 94(2). 259–267. 424 indexed citations
9.
Fermeaux, V., et al.. (2006). [Pathological characteristics in screening versus clinically-detected breast cancer].. PubMed. 93(7). 731–6. 3 indexed citations
10.
Decroisette, C., et al.. (2006). Métastases pleurales d’un fibrosarcome épithélioïde sclérosant. Revue de Pneumologie Clinique. 62(3). 179–182. 5 indexed citations
11.
Hantz, Sébastien, et al.. (2005). Comparaison de deux techniques de détection et de typage des papillomavirus humains : Hybrid Capture® 2 et HPV Consensus kit®. Pathologie Biologie. 53(8-9). 556–562. 2 indexed citations
12.
Fermeaux, V., et al.. (2005). Une pseudo-carcinose péritonéale de la jeune femme : la gliomatose péritonéale. Gastroentérologie Clinique et Biologique. 29(6-7). 740–742. 4 indexed citations
13.
Aubard, Y., et al.. (2004). Comment éviter les aléas de l’examen extemporané du ganglion sentinelle dans le cancer du sein ?. Gynécologie Obstétrique & Fertilité. 32(11). 981–984. 6 indexed citations
14.
Bourthoumieu, Sylvie, et al.. (2004). Two unusual chromosome aberrations ascertained by sonographic anomalies. Prenatal Diagnosis. 24(3). 219–223. 5 indexed citations
15.
Mathonnet, Muriel & V. Fermeaux. (2003). [Colon cancer in pregnancy].. PubMed. 140(4). 221–4. 4 indexed citations
16.
Aubard, Y., et al.. (1999). Orthotopic and heterotopic autografts of frozen–thawed ovarian cortex in sheep. Human Reproduction. 14(8). 2149–2154. 176 indexed citations
17.
Colombeau, P, et al.. (1998). Renal Lesions in von Hippel-Lindau Disease: The Benign, the Malignant, the Unknown. European Urology. 34(5). 383–392. 6 indexed citations
18.
Aubard, Y., et al.. (1998). Double maternal seroconversion to cytomegalovirus and Toxoplasma gondii. European Journal of Obstetrics & Gynecology and Reproductive Biology. 80(2). 275–278. 2 indexed citations
19.
Liozon, É., Christophe Brigaudeau, Franck Trimoreau, et al.. (1997). Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature. PubMed. 39(1). 11–18. 40 indexed citations
20.
Guéret, Pascal, et al.. (1996). Acute limb ischemia and heparin-induced thrombocytopenia: The value of echocardiography in eliminating a cardiac source of arterial emboli. Journal of the American Society of Echocardiography. 9(3). 344–347. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026